LY2940680

Modify Date: 2025-08-25 19:10:11

LY2940680 Structure
LY2940680 structure
Common Name LY2940680
CAS Number 1258861-20-9 Molecular Weight 512.502
Density 1.4±0.1 g/cm3 Boiling Point 703.5±60.0 °C at 760 mmHg
Molecular Formula C26H24F4N6O Melting Point N/A
MSDS N/A Flash Point 379.3±32.9 °C

 Use of LY2940680


Taladegib (LY2940680) is an antagonist of the smoothened receptor.

 Names

Name 4-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-2-(trifluoromethyl)benzamide
Synonym More Synonyms

 LY2940680 Biological Activity

Description Taladegib (LY2940680) is an antagonist of the smoothened receptor.
Related Catalog
Target

Smo[1]

In Vitro Taladegib, a small-molecule antagonist of the smoothened receptor, shows a slight inhibitory effect on cell proliferation without differences between mucin- (IC50: Taladegib=49.8±4.5 μM) and mixed- Cholangiocarcinoma (CCA) (IC50: Taladegib=61.2±21.1 μM)[1]. The IC50 for Taladegib inhibition of [3H]MRT-92 binding is right shifted (3- to 100-fold) for the S387AECL2, L325F3.36f, and D473H6.54f mutants but did not differ from that of WT receptor for the other mutants. The ability of SANT-1 to inhibit [3H]MRT-92 binding to V329F3.40f and T466F6.47f mutants is abolished, and it is severely impaired for L325F3.40f, I408F5.51f, and M525G7.45f mutants (4- to 140-fold drop of the IC50), but is not modified for the S387AECL2 mutant. Taken together, these data confirm our docking hypothesis that MRT-92-binding mode differs from that of either Taladegib or SANT-1 by simultaneously occupying binding sites 1 and 2[2].
References

[1]. Fraveto A, et al, Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures. PLoS One. 2015 Nov 16;10(11):e0142124.

[2]. Hoch L, et al. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor. FASEB J. 2015 May;29(5):1817-29.

[3]. Ma W, et al. Reduced Smoothened level rescued Aβ-induced memory deficits and neuronal inflammation in animal models of Alzheimer's disease. J Genet Genomics. 2018 May 20;45(5):237-246.

 Chemical & Physical Properties

Density 1.4±0.1 g/cm3
Boiling Point 703.5±60.0 °C at 760 mmHg
Molecular Formula C26H24F4N6O
Molecular Weight 512.502
Flash Point 379.3±32.9 °C
Exact Mass 512.194763
PSA 67.15000
LogP 2.70
Vapour Pressure 0.0±2.2 mmHg at 25°C
Index of Refraction 1.634
Storage condition -20°C

 Safety Information

Hazard Codes Xi

 Synthetic Route

~83%

LY2940680 Structure

LY2940680

CAS#:1258861-20-9

Literature: US2010/324048 A1, ; Page/Page column 6 ;

 Precursor & DownStream

Precursor  1

DownStream  0

 LY2940680Bioassay

View more

Name: Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident pro...
Source: NCGC
Target: N/A
External Id: SERCaMPGLuc-p1-antagonist
Name: Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Source: NCGC
External Id: SNCA-p-activity-luciferase
Name: Primary qHTS for Identification of Small Molecule Activators of Huntingtin-Antisense ...
Source: NCGC
External Id: huntington-HTTAS8-p1-FF-overN
Name: Cytotoxicity counterscreen for inhibitors of SARS-CoV-2 cell entry
Source: NCGC
Target: N/A
External Id: TRND-SARS-CoV-2-cytotox-48hr
Name: Primary qHTS to identify inhibitors of SARS-CoV-2 cell entry
Source: NCGC
External Id: TRND-SARS-CoV-2-PP
Name: Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against th...
Source: NCGC
Target: N/A
External Id: s-my-keats_OPM1-m4-1
Total 139, Current Page 1 of 14
1
2
3
4
5

 Synonyms

Taladegib
4-Fluoro-N-methyl-N-{1-[4-(1-methyl-1H-pyrazol-5-yl)-1-phthalazinyl]-4-piperidinyl}-2-(trifluoromethyl)benzamide
LY 2940680
LY2940680
4-fluoro-N-methyl-N-(1-(4-(1-methyl-1H-pyrazol-5-yl)phthalazin-1-yl)piperidin-4-yl)-2-(trifluoromethyl)benzamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.